Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company, 60900-60903 [2018-25865]
Download as PDF
<![CDATA[
60900
Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices
The company plans to manufacture
bulk synthetic active pharmaceutical
ingredients (APIs) for product
development and distribution to its
customers. No other activity for these
drug codes are authorized for this
registration.
Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–25862 Filed 11–26–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Fisher Clinical Services,
Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
DATES:
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 27, 2018. Such
persons may also file a written request
for a hearing on the application on or
before December 27, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
September 27, 2018, Fisher Clinical
Services, Inc., 700A–C Nestle Way,
Breinigsville, Pennsylvania 18031, has
applied to be registered as an importer
of the below listed basic classes of
controlled substances listed in schedule
I & II.
Controlled substance
Drug code
Psilocybin .................................................................................................................................................................
Methylphenidate .......................................................................................................................................................
Levorphanol .............................................................................................................................................................
Noroxymorphone .....................................................................................................................................................
Tapentadol ...............................................................................................................................................................
The company plans to import the
listed controlled substances for
analytical research, testing, and clinical
trials. This authorization does not
extend to the import of a finished FDA
approved or non-approved dosage form
for commercial distribution in the
United States.
DEPARTMENT OF JUSTICE
Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
ACTION:
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cayman
Chemical Company
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 28, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
DATES:
[FR Doc. 2018–25872 Filed 11–26–18; 8:45 am]
BILLING CODE 4410–09–P
amozie on DSK3GDR082PROD with NOTICES1
Drug Enforcement Administration
Jkt 247001
PO 00000
Frm 00080
Fmt 4703
I
II
II
II
II
Drug code
3-Fluoro-N-methylcathinone (3–FMC) .......................................................................................................................
Cathinone ...................................................................................................................................................................
Methcathinone ............................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .......................................................................................................................
17:45 Nov 26, 2018
7437
1724
9220
9668
9780
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 25,
2018, Cayman Chemical Company, 1180
East Ellsworth Road, Ann Arbor,
Michigan 48108 applied to be registered
as a bulk manufacturer for the basic
classes of controlled substances:
Controlled substance
VerDate Sep<11>2014
Schedule
Sfmt 4703
E:\FR\FM\27NON1.SGM
27NON1
1233
1235
1237
1238
Schedule
I
I
I
I
60901
Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices
amozie on DSK3GDR082PROD with NOTICES1
Controlled substance
Drug code
Pentedrone (a-methylaminovalerophenone) ..............................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ...............................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) ..........................................................................................................................
Naphyrone ..................................................................................................................................................................
N-Ethylamphetamine ..................................................................................................................................................
N,N-Dimethylamphetamine ........................................................................................................................................
Fenethylline ................................................................................................................................................................
Aminorex ....................................................................................................................................................................
4-Methylaminorex (cis isomer) ...................................................................................................................................
Gamma Hydroxybutyric Acid .....................................................................................................................................
Methaqualone .............................................................................................................................................................
Mecloqualone .............................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ............................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ..........................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .......
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ...........
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) .................................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .................
2-(1-(4-fluorobenzyl)-1Hinsazole-3-carboxamido)-3-methylbutanoate .......................................................................
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ....................................
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ..............................................................
5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2yl)-1-(5-fluoropentyl)-1 H-indazole-3-carboxamide) ...............
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ...........
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ..
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .........................................
5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ...........................
MDMB–CHMICA,
MMB–CHMINACA
(Methyl
2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate).
MMB–CHMICA, AMB–CHMICA (methyl 2-(1(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3methylbutanoate) ...
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .........................................................
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .............................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ............................................................................................
5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3carboxamide) ...........
4–CN–CUMYL–BUTINACA (1-(4-cyanobutyl)-N-(2phenylpropan-2-yl)-1 H-indazole-3-carboxamide) .....................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ...............................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ........................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ...............................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ...........................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ..................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .....................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) .................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ................................................................................................
NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)1 H-indole-3-carboxylate) ....................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ...........................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .......................................................................
Alpha-ethyltryptamine .................................................................................................................................................
Ibogaine ......................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ...........................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .....................................
Lysergic acid diethylamide .........................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) .........................................................................................
Marihuana ..................................................................................................................................................................
Tetrahydrocannabinols ...............................................................................................................................................
Mescaline ...................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) .....................................................................................
3,4,5-Trimethoxyamphetamine ...................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ........................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ....................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ........................................................................................................................
2,5-Dimethoxyamphetamine ......................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ..........................................................................................................................
3,4-Methylenedioxyamphetamine ..............................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ............................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ............................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ..................................................................................................................
3,4-Methylenedioxymethamphetamine ......................................................................................................................
4-Methoxyamphetamine .............................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine ............................................................................................................................
Alpha-methyltryptamine ..............................................................................................................................................
Diethyltryptamine ........................................................................................................................................................
Dimethyltryptamine .....................................................................................................................................................
VerDate Sep<11>2014
17:45 Nov 26, 2018
Jkt 247001
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
E:\FR\FM\27NON1.SGM
27NON1
Schedule
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7019
7020
7021
7023
7024
7025
7031
7032
7033
7034
7035
7042
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7044
7048
7049
7081
7085
7089
7104
7118
7122
7144
7173
7200
7201
7203
7221
7222
7225
7249
7260
7297
7298
7315
7348
7360
7370
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7434
7435
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
60902
Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices
amozie on DSK3GDR082PROD with NOTICES1
Controlled substance
Drug code
Psilocybin ...................................................................................................................................................................
Psilocyn ......................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ........................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ..............................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ..............................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ..........................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .........................................................................................................................
N-Benzylpiperazine ....................................................................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) ............................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ..............................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ...........................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ..................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) .............................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ...............................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ........................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) .............................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ...............................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ...............................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ...................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) .................................................................................................
Butylone .....................................................................................................................................................................
Pentylone ...................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ...................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) .....................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ..............................................................................................
Acetyldihydrocodeine .................................................................................................................................................
Benzylmorphine ..........................................................................................................................................................
Codeine-N-oxide ........................................................................................................................................................
Desomorphine ............................................................................................................................................................
Etorphine (except HCl) ...............................................................................................................................................
Codeine methylbromide .............................................................................................................................................
Dihydromorphine ........................................................................................................................................................
Heroin .........................................................................................................................................................................
Morphine-N-oxide .......................................................................................................................................................
Normorphine ...............................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .........................................................
MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) .............................................................................................
Tilidine ........................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ...........................................................................
Para-Fluorofentanyl ....................................................................................................................................................
3-Methylfentanyl .........................................................................................................................................................
Alpha-methylfentanyl ..................................................................................................................................................
Acetyl-alpha-methylfentanyl .......................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ..................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .........................................................................
Butyryl Fentanyl .........................................................................................................................................................
Para-fluorobutyryl fentanyl .........................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ...................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ....................................................................................
Para-chloroisobutyryl fentanyl ....................................................................................................................................
Isobutyryl fentanyl ......................................................................................................................................................
Beta-hydroxyfentanyl ..................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ...................................................................................................................................
Alpha-methylthiofentanyl ............................................................................................................................................
3-Methylthiofentanyl ...................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ........................................................
Thiofentanyl ................................................................................................................................................................
Beta-hydroxythiofentanyl ............................................................................................................................................
Para-methoxybutyryl fentanyl .....................................................................................................................................
Ocfentanil ...................................................................................................................................................................
Valeryl fentanyl ...........................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .....................................................................
Cyclopropyl Fentanyl ..................................................................................................................................................
Cyclopentyl fentanyl ...................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11&h) ..............................................................................
Amphetamine .............................................................................................................................................................
Methamphetamine ......................................................................................................................................................
Lisdexamfetamine ......................................................................................................................................................
Phenmetrazine ...........................................................................................................................................................
Methylphenidate .........................................................................................................................................................
Amobarbital ................................................................................................................................................................
Pentobarbital ..............................................................................................................................................................
Secobarbital ...............................................................................................................................................................
VerDate Sep<11>2014
17:45 Nov 26, 2018
Jkt 247001
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
E:\FR\FM\27NON1.SGM
27NON1
7437
7438
7439
7455
7458
7470
7473
7493
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
9051
9052
9053
9055
9056
9070
9145
9200
9307
9313
9547
9560
9750
9811
9812
9813
9814
9815
9816
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9840
9843
9845
9847
9850
1100
1105
1205
1631
1724
2125
2270
2315
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
60903
Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices
Controlled substance
Drug code
Phencyclidine .............................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) ...............................................................................................................
Phenylacetone ............................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ...........................................................................................................................
Cocaine ......................................................................................................................................................................
Codeine ......................................................................................................................................................................
Etorphine HCl .............................................................................................................................................................
Dihydrocodeine ..........................................................................................................................................................
Oxycodone .................................................................................................................................................................
Hydromorphone ..........................................................................................................................................................
Ecgonine ....................................................................................................................................................................
Ethylmorphine ............................................................................................................................................................
Hydrocodone ..............................................................................................................................................................
Levomethorphan ........................................................................................................................................................
Levorphanol ................................................................................................................................................................
Isomethadone .............................................................................................................................................................
Meperidine ..................................................................................................................................................................
Meperidine intermediate-B .........................................................................................................................................
Methadone .................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ........................................................................................................
Morphine ....................................................................................................................................................................
Thebaine ....................................................................................................................................................................
Oxymorphone .............................................................................................................................................................
Thiafentanil .................................................................................................................................................................
Alfentanil .....................................................................................................................................................................
Remifentanil ...............................................................................................................................................................
Sufentanil ...................................................................................................................................................................
Carfentanil ..................................................................................................................................................................
Tapentadol .................................................................................................................................................................
Fentanyl ......................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances to produce forensic and
research analytical reference standards
for distribution to its customers.
issuance of the proposed registration on
or before December 27, 2018. Such
persons may also file a written request
for a hearing on the application on or
before December 27, 2018.
Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
ADDRESSES:
[FR Doc. 2018–25865 Filed 11–26–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Drug Enforcement Administration
Importer of Controlled Substances
Application: Sigma Aldrich Co., LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
SUPPLEMENTARY INFORMATION:
amozie on DSK3GDR082PROD with NOTICES1
Jkt 247001
PO 00000
Frm 00083
Fmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Drug code
Cathinone ................................................................................................................................................................
Methcathinone .........................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................
Aminorex .................................................................................................................................................................
Gamma Hydroxybutyric Acid ...................................................................................................................................
Methaqualone ..........................................................................................................................................................
Alpha-ethyltryptamine ..............................................................................................................................................
Ibogaine ...................................................................................................................................................................
Lysergic acid diethylamide ......................................................................................................................................
17:45 Nov 26, 2018
7471
8333
8501
8603
9041
9050
9059
9120
9143
9150
9180
9190
9193
9210
9220
9226
9230
9233
9250
9273
9300
9333
9652
9729
9737
9739
9740
9743
9780
9801
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
February 21, 2018, Sigma Aldrich Co.,
LLC, 3500 Dekalb Street, Saint Louis,
Missouri 63118 applied to be registered
as an importer of the following basic
classes of controlled substances:
Controlled substance
VerDate Sep<11>2014
Schedule
Sfmt 4703
E:\FR\FM\27NON1.SGM
27NON1
1235
1237
1248
1585
2010
2565
7249
7260
7315
Schedule
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 83, Number 228 (Tuesday, November 27, 2018)]
[Notices]
[Pages 60900-60903]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25865]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Cayman
Chemical Company
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before January 28, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on July
25, 2018, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor,
Michigan 48108 applied to be registered as a bulk manufacturer for the
basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3- 1233 I
FMC).
Cathinone........................ 1235 I
Methcathinone.................... 1237 I
4-Fluoro-N-methylcathinone (4- 1238 I
FMC).
[[Page 60901]]
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC) 1249 I
Naphyrone........................ 1258 I
N-Ethylamphetamine............... 1475 I
N,N-Dimethylamphetamine.......... 1480 I
Fenethylline..................... 1503 I
Aminorex......................... 1585 I
4-Methylaminorex (cis isomer).... 1590 I
Gamma Hydroxybutyric Acid........ 2010 I
Methaqualone..................... 2565 I
Mecloqualone..................... 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3- 7010 I
dimethyl-1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-
carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5- 7011 I
Fluoro-pentyl)1H-indol-3-
yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl- 7012 I
1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-
carboxamide).
JWH-019 (1-Hexyl-3-(1- 7019 I
naphthoyl)indole).
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-
carboxamido)-3,3-
dimethylbutanoate).
2-(1-(4-fluorobenzyl)-1Hinsazole- 7021 I
3-carboxamido)-3-methylbutanoate.
AB-PINACA (N-(1-amino-3-methyl-1- 7023 I
oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H- 7024 I
indazol-3-yl](naphthalen-1-
yl)methanone.
5F-AB-PINACA (N-(1-amino-3-methyl- 7025 I
1-oxobutan-2yl)-1-(5-
fluoropentyl)-1 H-indazole-3-
carboxamide).
AB-CHMINACA (N-(1-amino-3-methyl- 7031 I
1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide.
MAB-CHMINACA (N-(1-amino- 7032 I
3,3dimethyl-1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
5F-AMB (Methyl 2-(1-(5- 7033 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3-methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2- 7034 I
(1-(5-fluoropentyl)-1H-indazole-
3-carboxamido)-3,3-
dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3- 7035 I
dimethyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-
carboxamide).
MDMB-CHMICA, MMB-CHMINACA (Methyl 7042 I
2-(1-(cyclohexylmethyl)-1H-
indole-3-carboxamido)-3,3-
dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2- 7044 I
(1(cyclohexylmethyl)-1 H-indole-
3-carboxamido)-3methylbutanoate).
APINACA and AKB48 N-(1-Adamantyl)- 7048 I
1-pentyl-1H-indazole-3-
carboxamide.
5F-APINACA, 5F-AKB48 (N- 7049 I
(adamantan-1-yl)-1-(5-
fluoropentyl)-1H-indazole-3-
carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
5F-CUMYL-P7AICA (1-(5- 7085 I
fluoropentyl)-N-(2phenylpropan-2-
yl)-1 H-pyrrolo[2,3-b]pyridine-
3carboxamide).
4-CN-CUMYL-BUTINACA (1-(4- 7089 I
cyanobutyl)-N-(2phenylpropan-2-
yl)-1 H-indazole-3-carboxamide).
SR-19 (Also known as RCS-4) (1- 7104 I
Pentyl-3-[(4-methoxy)-benzoyl]
indole.
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3- 7144 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4- 7200 I
Morpholinyl)ethyl]-3-(1-
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
NM2201; CBL2201 (Naphthalen-1-yl 7221 I
1-(5-fluoropentyl)1 H-indole-3-
carboxylate).
PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I
indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-
carboxylate).
Alpha-ethyltryptamine............ 7249 I
Ibogaine......................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)- 7297 I
2-[(1R,3S)-3-hydroxycyclohexyl-
phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide....... 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-
7).
Marihuana........................ 7360 I
Tetrahydrocannabinols............ 7370 I
Mescaline........................ 7381 I
2-(4-Ethylthio-2,5- 7385 I
dimethoxyphenyl) ethanamine (2C-
T-2 ).
3,4,5-Trimethoxyamphetamine...... 7390 I
4-Bromo-2,5-dimethoxyamphetamine. 7391 I
4-Bromo-2,5- 7392 I
dimethoxyphenethylamine.
4-Methyl-2,5-dimethoxyamphetamine 7395 I
2,5-Dimethoxyamphetamine......... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine. 7399 I
3,4-Methylenedioxyamphetamine.... 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4-Methylenedioxymethamphetamine 7405 I
4-Methoxyamphetamine............. 7411 I
5-Methoxy-N-N-dimethyltryptamine. 7431 I
Alpha-methyltryptamine........... 7432 I
Diethyltryptamine................ 7434 I
Dimethyltryptamine............... 7435 I
[[Page 60902]]
Psilocybin....................... 7437 I
Psilocyn......................... 7438 I
5-Methoxy-N,N- 7439 I
diisopropyltryptamine.
N-Ethyl-1-phenylcyclohexylamine.. 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine 7458 I
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
1-[1-(2- 7473 I
Thienyl)cyclohexyl]pyrrolidine.
N-Benzylpiperazine............... 7493 I
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) 7517 I
ethanamine (2C-H).
2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl) ethanamine (2C-P).
2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine (2C-
T-4 ).
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
2-(4-bromo-2,5-dimethoxyphenyl)-N- 7536 I
(2-methoxybenzyl) ethanamine
(25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)- 7537 I
N-(2-methoxybenzyl) ethanamine
(25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N- 7538 I
(2-methoxybenzyl) ethanamine
(25I-NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone......................... 7541 I
Pentylone........................ 7542 I
alpha-pyrrolidinopentiophenone 7545 I
([alpha]-PVP).
alpha-pyrrolidinobutiophenone 7546 I
([alpha]-PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Acetyldihydrocodeine............. 9051 I
Benzylmorphine................... 9052 I
Codeine-N-oxide.................. 9053 I
Desomorphine..................... 9055 I
Etorphine (except HCl)........... 9056 I
Codeine methylbromide............ 9070 I
Dihydromorphine.................. 9145 I
Heroin........................... 9200 I
Morphine-N-oxide................. 9307 I
Normorphine...................... 9313 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Tilidine......................... 9750 I
Acryl fentanyl (N-(1- 9811 I
phenethylpiperidin-4-yl)-N-
phenylacrylamide).
Para-Fluorofentanyl.............. 9812 I
3-Methylfentanyl................. 9813 I
Alpha-methylfentanyl............. 9814 I
Acetyl-alpha-methylfentanyl...... 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-
yl)propionamide.
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl................. 9822 I
Para-fluorobutyryl fentanyl...... 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-
phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin- 9825 I
4-yl)-N-phenylacetamide.
Para-chloroisobutyryl fentanyl... 9826 I
Isobutyryl fentanyl.............. 9827 I
Beta-hydroxyfentanyl............. 9830 I
Beta-hydroxy-3-methylfentanyl.... 9831 I
Alpha-methylthiofentanyl......... 9832 I
3-Methylthiofentanyl............. 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl..................... 9835 I
Beta-hydroxythiofentanyl......... 9836 I
Para-methoxybutyryl fentanyl..... 9837 I
Ocfentanil....................... 9838 I
Valeryl fentanyl................. 9840 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-
carboxamide.
Cyclopropyl Fentanyl............. 9845 I
Cyclopentyl fentanyl............. 9847 I
Fentanyl related-compounds as 9850 I
defined in 21 CFR 1308.11&h).
Amphetamine...................... 1100 II
Methamphetamine.................. 1105 II
Lisdexamfetamine................. 1205 II
Phenmetrazine.................... 1631 II
Methylphenidate.................. 1724 II
Amobarbital...................... 2125 II
Pentobarbital.................... 2270 II
Secobarbital..................... 2315 II
[[Page 60903]]
Phencyclidine.................... 7471 II
4-Anilino-N-phenethyl-4- 8333 II
piperidine (ANPP).
Phenylacetone.................... 8501 II
1- 8603 II
Piperidinocyclohexanecarbonitril
e.
Cocaine.......................... 9041 II
Codeine.......................... 9050 II
Etorphine HCl.................... 9059 II
Dihydrocodeine................... 9120 II
Oxycodone........................ 9143 II
Hydromorphone.................... 9150 II
Ecgonine......................... 9180 II
Ethylmorphine.................... 9190 II
Hydrocodone...................... 9193 II
Levomethorphan................... 9210 II
Levorphanol...................... 9220 II
Isomethadone..................... 9226 II
Meperidine....................... 9230 II
Meperidine intermediate-B........ 9233 II
Methadone........................ 9250 II
Dextropropoxyphene, bulk (non- 9273 II
dosage forms).
Morphine......................... 9300 II
Thebaine......................... 9333 II
Oxymorphone...................... 9652 II
Thiafentanil..................... 9729 II
Alfentanil....................... 9737 II
Remifentanil..................... 9739 II
Sufentanil....................... 9740 II
Carfentanil...................... 9743 II
Tapentadol....................... 9780 II
Fentanyl......................... 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances to produce forensic and research analytical reference
standards for distribution to its customers.
Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-25865 Filed 11-26-18; 8:45 am]
BILLING CODE 4410-09-P
